ArticleCancer research and treatment2016

The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo.

Keun-Yong Eom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.